Piperazine‐designed α1A/α1D‐adrenoceptor blocker KMUP‐1 and doxazosin provide down‐regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Piperazine‐designed α1A/α1D‐adrenoceptor blocker KMUP‐1 and doxazosin provide down‐regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts

Authors:	Chi‐Ming Liu Yi‐Ching Lo Ming‐Hong Tai Bin‐Nan Wu Wen‐Jeng Wu Yii‐Her Chou Chee‐Yin Chai Chun‐Hsiung Huang Ing‐Jun Chen

Affiliation:	1. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;2. Department and Graduate Institute of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;3. Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan;4. Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;5. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Abstract:

Keywords:	cell cycle chemoprevention prostate cancer